Bio Warriors Pharmaceucticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Revenue -34.89%
(FY 2021)
- Profit -429.04%
(FY 2021)
- Ebitda -264.77%
(FY 2021)
- Net Worth -48.71%
(FY 2021)
- Total Assets -16.79%
(FY 2021)
About Bio Warriors Pharmaceucticals
The Corporate was formerly known as Nexpro Solutions Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Champa Shetty, Sudha Padmanabha, Shanthala Gopalakrishna, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232KA2007PTC044018
- Company No.
044018
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Oct 2007
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bio Warriors Pharmaceucticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudha Padmanabha  | Director | 04-May-2012 | Current |
| Kanniappan Venkatesh | Director | 09-Apr-2012 | Current |
| Champa Shetty | Director | 01-Oct-2007 | Current |
| Shanthala Gopalakrishna | Director | 04-May-2012 | Current |
| Shobha | Director | 04-Oct-2018 | Current |
Financial Performance and Corporate Structure Insights of Bio Warriors Pharmaceucticals.
Bio Warriors Pharmaceucticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 34.89% decrease. The company also saw a substantial fall in profitability, with a 429.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 48.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bio Warriors Pharmaceucticals?
In 2021, Bio Warriors Pharmaceucticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jan Arogya Pharma India Private Limited
Active 3 years 6 monthsKanniappan Venkatesh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bio Warriors Pharmaceucticals?
Bio Warriors Pharmaceucticals has a workforce of 32 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio Warriors Pharmaceucticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio Warriors Pharmaceucticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
